Search

Joseph A Kaufman

Examiner (ID: 10129)

Most Active Art Unit
3754
Art Unit(s)
3752, 3993, 3727, 3754, 3108, 3104
Total Applications
1964
Issued Applications
1543
Pending Applications
181
Abandoned Applications
196

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5682584 [patent_doc_number] => 20060198854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Vector platforms derived from the alphavirus vaccines' [patent_app_type] => utility [patent_app_number] => 11/319214 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10827 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20060198854.pdf [firstpage_image] =>[orig_patent_app_number] => 11319214 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/319214
Vector platforms derived from the alphavirus vaccines Dec 27, 2005 Abandoned
Array ( [id] => 5655866 [patent_doc_number] => 20060141602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Packaging of positive-strand RNA virus replicon particles' [patent_app_type] => utility [patent_app_number] => 11/297316 [patent_app_country] => US [patent_app_date] => 2005-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 17597 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141602.pdf [firstpage_image] =>[orig_patent_app_number] => 11297316 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/297316
Packaging of positive-strand RNA virus replicon particles Dec 7, 2005 Abandoned
Array ( [id] => 8921139 [patent_doc_number] => 08487076 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-07-16 [patent_title] => 'HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide' [patent_app_type] => utility [patent_app_number] => 11/814709 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6636 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11814709 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/814709
HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide Dec 5, 2005 Issued
Array ( [id] => 5415837 [patent_doc_number] => 20090041724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Protein Delivery System' [patent_app_type] => utility [patent_app_number] => 11/791917 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9380 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041724.pdf [firstpage_image] =>[orig_patent_app_number] => 11791917 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/791917
Protein Delivery System Dec 4, 2005 Abandoned
Array ( [id] => 509181 [patent_doc_number] => 07195915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-27 [patent_title] => 'Vectors for animal cells and use thereof' [patent_app_type] => utility [patent_app_number] => 11/284905 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14555 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/195/07195915.pdf [firstpage_image] =>[orig_patent_app_number] => 11284905 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/284905
Vectors for animal cells and use thereof Nov 22, 2005 Issued
Array ( [id] => 5921283 [patent_doc_number] => 20060239972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Adiponectin gene therapy' [patent_app_type] => utility [patent_app_number] => 11/285689 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9712 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20060239972.pdf [firstpage_image] =>[orig_patent_app_number] => 11285689 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/285689
Adiponectin gene therapy Nov 21, 2005 Abandoned
Array ( [id] => 806595 [patent_doc_number] => 07419827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-02 [patent_title] => 'Cell lines' [patent_app_type] => utility [patent_app_number] => 11/283621 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12224 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/419/07419827.pdf [firstpage_image] =>[orig_patent_app_number] => 11283621 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/283621
Cell lines Nov 20, 2005 Issued
Array ( [id] => 5828154 [patent_doc_number] => 20060063234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Efficient production of IgM in recombinant mammalian cells' [patent_app_type] => utility [patent_app_number] => 11/271090 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6733 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063234.pdf [firstpage_image] =>[orig_patent_app_number] => 11271090 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/271090
Efficient production of IgM in recombinant mammalian cells Nov 8, 2005 Abandoned
Array ( [id] => 5872858 [patent_doc_number] => 20060165658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/267275 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24929 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165658.pdf [firstpage_image] =>[orig_patent_app_number] => 11267275 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/267275
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof Nov 6, 2005 Abandoned
Array ( [id] => 6529754 [patent_doc_number] => 20100015211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Combination Approaches For Generating Immune Responses' [patent_app_type] => utility [patent_app_number] => 11/664962 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30881 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015211.pdf [firstpage_image] =>[orig_patent_app_number] => 11664962 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/664962
Combination Approaches For Generating Immune Responses Oct 31, 2005 Abandoned
Array ( [id] => 5141821 [patent_doc_number] => 20070004037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Methods and compositions for culturing keratinocytes' [patent_app_type] => utility [patent_app_number] => 11/258346 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11383 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004037.pdf [firstpage_image] =>[orig_patent_app_number] => 11258346 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/258346
Methods and compositions for culturing keratinocytes Oct 23, 2005 Abandoned
Array ( [id] => 5674140 [patent_doc_number] => 20060179495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Tumor model with chromosomal rearrangement and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/255618 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11130 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20060179495.pdf [firstpage_image] =>[orig_patent_app_number] => 11255618 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/255618
Tumor model with chromosomal rearrangement and uses thereof Oct 20, 2005 Abandoned
Array ( [id] => 5726870 [patent_doc_number] => 20060057630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia' [patent_app_type] => utility [patent_app_number] => 11/256381 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21840 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057630.pdf [firstpage_image] =>[orig_patent_app_number] => 11256381 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/256381
MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia Oct 19, 2005 Abandoned
Array ( [id] => 5800445 [patent_doc_number] => 20060035371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Hybrid adeno-retroviral vector for the transfection of cells' [patent_app_type] => utility [patent_app_number] => 11/255059 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21667 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035371.pdf [firstpage_image] =>[orig_patent_app_number] => 11255059 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/255059
Hybrid adeno-retroviral vector for the transfection of cells Oct 18, 2005 Issued
Array ( [id] => 5760172 [patent_doc_number] => 20060211117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Methods of making minicircles' [patent_app_type] => utility [patent_app_number] => 11/249929 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13538 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211117.pdf [firstpage_image] =>[orig_patent_app_number] => 11249929 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/249929
Methods of making minicircles Oct 12, 2005 Abandoned
Array ( [id] => 5655185 [patent_doc_number] => 20060140920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain' [patent_app_type] => utility [patent_app_number] => 11/244067 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12513 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140920.pdf [firstpage_image] =>[orig_patent_app_number] => 11244067 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/244067
Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain Oct 5, 2005 Abandoned
Array ( [id] => 5636945 [patent_doc_number] => 20060067918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Cell lines' [patent_app_type] => utility [patent_app_number] => 11/238702 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12168 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20060067918.pdf [firstpage_image] =>[orig_patent_app_number] => 11238702 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/238702
Cell lines Sep 28, 2005 Issued
Array ( [id] => 5912959 [patent_doc_number] => 20060128021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Unusual retrotransposon from the yeast Candida albicans' [patent_app_type] => utility [patent_app_number] => 11/238031 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 113 [patent_figures_cnt] => 113 [patent_no_of_words] => 34547 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128021.pdf [firstpage_image] =>[orig_patent_app_number] => 11238031 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/238031
Unusual retrotransposon from the yeast Candida albicans Sep 27, 2005 Abandoned
Array ( [id] => 5820421 [patent_doc_number] => 20060024734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia' [patent_app_type] => utility [patent_app_number] => 11/233905 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21849 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024734.pdf [firstpage_image] =>[orig_patent_app_number] => 11233905 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/233905
MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia Sep 21, 2005 Abandoned
Array ( [id] => 5820508 [patent_doc_number] => 20060024821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Rolling circle replicon expression vector' [patent_app_type] => utility [patent_app_number] => 11/231725 [patent_app_country] => US [patent_app_date] => 2005-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9313 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024821.pdf [firstpage_image] =>[orig_patent_app_number] => 11231725 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/231725
Rolling circle replicon expression vector Sep 19, 2005 Abandoned
Menu